Kristel Kemper

Kristel Kemper is a seasoned professional in translational research with extensive experience at Genmab since August 2017, where roles have included Director and Associate Director, among others. Prior to this, Kristel Kemper contributed to research at The Netherlands Cancer Institute from November 2011 to July 2017, focusing on metastatic melanoma and patient-derived xenografts while supervising a technician and co-authoring research grants. Earlier research included a PhD at the University of Amsterdam, concentrating on colorectal cancer stem cells, and a position as a student assistant in histology. Kristel Kemper holds a Master of Science degree in Biomedical Sciences from the University of Amsterdam.